You are here
Epitomics, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Technology for quantitating protein phosphorylation
Amount: $99,600.00DESCRIPTION (provided by applicant): The objective of this proposal is to develop a novel technology for detecting multiple protein markers for disease management. In this project, the technology wil ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Conformation-specific antibodies to protein kinases
Amount: $99,600.00DESCRIPTION (provided by applicant): In order to understand the pathogenesis of cancer, it will be critical to elucidate the cellular signaling pathways that contribute to oncogenic transformation. C ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Amplification of Proteins in Body Fluids for Early Detection of Biological Warfare Exposure
Amount: $69,916.00This SBIR Phase I project will lead to the development of a technology to detect very low levels of multiple pathogen-specific proteins or human proteins very quickly after exposure to biological warf ...
SBIRPhase I2004Department of Defense Army -
Sandwich ELISA using rabbit monoclonal antibodies for liver-stage malaria detection
Amount: $69,888.00Malaria is a major health problem worldwide, and its significance may be on the increase due to the rapid spread of parasite strains that are resistant to conventional anti-malaria drugs. Evidence sug ...
SBIRPhase I2003Department of Defense Army -
Development of High Throughput Molecular Profiles for the Detection and Staging of Cancer
Amount: $119,806.00This Small Business Innovation Research Phase I project aims to develop a technology that employs polyclonal antibodies as a complex probe to discover tumor associated surface antigens, a process name ...
SBIRPhase I2003Department of Defense Army -
Development of High Throughput Molecular Profiles for the Detection and Staging of Cancer
Amount: $729,500.00The discovery and identification of novel tumor associated antigens (TAAs) is critical for the advancement of accurate cancer diagnosis and staging. This Small Business Innovation Research Phase II p ...
SBIRPhase II2003Department of Defense Army